Join Dementia Research has reached 100,000 volunteers, but more are needed to drive breakthroughs in dementia research.

On 26 April 2026, Hilary crossed the finish line of the London Marathon. Then, 10 days later, she was made a Commander of the ...

Charlie Quirke, the son of Birds of a Feather star Pauline Quirke MBE who is living with dementia, led a team of runners at the TCS London Marathon.

It’s time for a national, government-led campaign on how to reduce the risk of dementia. Alzheimer’s Research UK asked the ...

We have produced a range of tip sheets to help you with different aspects of engaging people with your research. Lay summaries are really important to help members of the public understand dementia ...

We describe involvement to be when people use their experiences of living with, or supporting someone with, dementia to shape the design and delivery of research. Some researchers build long-term ...

Dementia UK is a specialist dementia nurse charity. Their nurses, called Admiral Nurses, provide ongoing support to families facing dementia. The Admiral Nurses help families manage complex needs, ...

A stipend in line with UKRI rates, PhD tuition fees at the Home rate and research/travel costs up to £15,000 per annum. This scheme is for a full PhD programme including a stipend, PhD tuition fees ...

This research strategy has been developed in collaboration with our Scientific Advisory Board, with input from people affected by dementia. It identifies and addresses the major opportunities for ...

Welcome to the Thames Valley Network Centre. The Network Centre unites dementia researchers across the Universities of Oxford, Reading and Oxford Brookes. Here you can find out more about Network ...

Walking, running, cycling, or golf, whichever event you choose, raise money for dementia research. From our first research project in 1998, we have now committed over £171 million of funding for ...

On this page you will find information about how to get involved in dementia research studies. Dementia research is at a turning point. Two new treatments have been licensed in many countries across ...